Changing paradigms of non-small cell lung cancer treatment

Francesco Guerrera^{1

2}, Fabrizio Tabbò³, Enrico Ruffini^{1

2}, Pietro Bertoglio⁴

Affiliations

¹ Department of Thoracic Surgery, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
² Department of Surgical Sciences, University of Torino, Torino, Italy.
³ Department of Oncology, University of Torino, Torino, Italy.
⁴ Division of Thoracic Surgery, Sacro Cuore-Don Calabria Research Hospital and Cancer Care Centre Negrar-Verona, Verona, Italy.

Editorial

Francesco Guerrera et al. J Thorac Dis. 2018 Nov.

. 2018 Nov;10(Suppl 33):S4170-S4172.

doi: 10.21037/jtd.2018.11.04.

Francesco Guerrera^{1

2}, Fabrizio Tabbò³, Enrico Ruffini^{1

2}, Pietro Bertoglio⁴

¹ Department of Thoracic Surgery, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
² Department of Surgical Sciences, University of Torino, Torino, Italy.
³ Department of Oncology, University of Torino, Torino, Italy.
⁴ Division of Thoracic Surgery, Sacro Cuore-Don Calabria Research Hospital and Cancer Care Centre Negrar-Verona, Verona, Italy.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors.
Bott MJ, Cools-Lartigue J, Tan KS, Dycoco J, Bains MS, Downey RJ, Huang J, Isbell JM, Molena D, Park BJ, Rusch VW, Sihag S, Jones DR, Adusumilli PS. Bott MJ, et al. Ann Thorac Surg. 2018 Jul;106(1):178-183. doi: 10.1016/j.athoracsur.2018.02.030. Epub 2018 Mar 14. Ann Thorac Surg. 2018. PMID: 29550207 Free PMC article.

1. Raju S, Joseph R, Sehgal S. Review of checkpoint immunotherapy for the management of non-small cell lung cancer. Immunotargets Ther 2018;7:63-75. 10.2147/ITT.S125070 - DOI - PMC - PubMed
1. Filosso PL, Guerrera F, Lausi PO, et al. Locally advanced non-small cell lung cancer treatment: another step forward. J Thorac Dis 2017;9:4908-11. 10.21037/jtd.2017.11.103 - DOI - PMC - PubMed
1. Ghysen K, Vansteenkiste J. Immunotherapy in patients with early stage resectable nonsmall cell lung cancer. Curr Opin Oncol 2018. [Epub ahead of print]. 10.1097/CCO.0000000000000497 - DOI - PubMed
1. Bott MJ, Cools-Lartigue J, Tan KS, et al. Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable Tumors. Ann Thorac Surg 2018;106:178-83. 10.1016/j.athoracsur.2018.02.030 - DOI - PMC - PubMed
1. Forde PM, Chaft JE, Pardoll DM. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. N Engl J Med 2018;379:e14. 10.1056/NEJMc1808251 - DOI - PubMed